| Letter to the Editor Online Published: 13 Oct 2020 | ||||||||||||
Low dose indomethacin for symptomatic treatment of COVID-19 Ravichandran Rajan, Srinivasan Subramanian, Chritine Clark.
| ||||||||||||
This Article Cited By the following articles
| Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19 Expert Review of Anti-infective Therapy 2021; (): 1. | 1 |
| An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients Sci Rep 2022; 12(1): . | 2 |
| Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19 Expert Review of Anti-infective Therapy 2022; 20(3): 383. | 3 |
| How to Cite this Article |
| Pubmed Style Rajan R, Subramanian S, Clark C. Low dose indomethacin for symptomatic treatment of COVID-19. Int J Med Rev Case Rep. 2020; 4(9): 69-70. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN Web Style Rajan R, Subramanian S, Clark C. Low dose indomethacin for symptomatic treatment of COVID-19. https://www.mdpub.net/?mno=121224 [Access: October 13, 2024]. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN AMA (American Medical Association) Style Rajan R, Subramanian S, Clark C. Low dose indomethacin for symptomatic treatment of COVID-19. Int J Med Rev Case Rep. 2020; 4(9): 69-70. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN Vancouver/ICMJE Style Rajan R, Subramanian S, Clark C. Low dose indomethacin for symptomatic treatment of COVID-19. Int J Med Rev Case Rep. (2020), [cited October 13, 2024]; 4(9): 69-70. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN Harvard Style Rajan, R., Subramanian, . S. & Clark, . C. (2020) Low dose indomethacin for symptomatic treatment of COVID-19. Int J Med Rev Case Rep, 4 (9), 69-70. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN Turabian Style Rajan, Ravichandran, Srinivasan Subramanian, and Chritine Clark. 2020. Low dose indomethacin for symptomatic treatment of COVID-19. International Journal of Medical Reviews and Case Reports, 4 (9), 69-70. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN Chicago Style Rajan, Ravichandran, Srinivasan Subramanian, and Chritine Clark. "Low dose indomethacin for symptomatic treatment of COVID-19." International Journal of Medical Reviews and Case Reports 4 (2020), 69-70. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN MLA (The Modern Language Association) Style Rajan, Ravichandran, Srinivasan Subramanian, and Chritine Clark. "Low dose indomethacin for symptomatic treatment of COVID-19." International Journal of Medical Reviews and Case Reports 4.9 (2020), 69-70. Print. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN APA (American Psychological Association) Style Rajan, R., Subramanian, . S. & Clark, . C. (2020) Low dose indomethacin for symptomatic treatment of COVID-19. International Journal of Medical Reviews and Case Reports, 4 (9), 69-70. doi:10.5455/IJMRCR.LOW-DOSE-INDOMETHACIN |
